![Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19 | Hypertension Research Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19 | Hypertension Research](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41440-020-0515-0/MediaObjects/41440_2020_515_Fig1_HTML.png)
Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19 | Hypertension Research
![The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19: Molecular Therapy - Methods & Clinical Development The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/3c6d1b63-ec40-4fab-9509-c5b24041ec23/gr1_lrg.jpg)
The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19: Molecular Therapy - Methods & Clinical Development
![Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine](https://www.cebm.net/wp-content/uploads/2020/03/RAS2.jpg)
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
![Role of the ACE2/Angiotensin 1–7 Axis of the Renin–Angiotensin System in Heart Failure | Circulation Research Role of the ACE2/Angiotensin 1–7 Axis of the Renin–Angiotensin System in Heart Failure | Circulation Research](https://www.ahajournals.org/cms/asset/8d1b070b-7bd0-43bd-bf8a-349b3c5496cb/1313fig01.jpg)
Role of the ACE2/Angiotensin 1–7 Axis of the Renin–Angiotensin System in Heart Failure | Circulation Research
![In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression | Molecular Systems Biology In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression | Molecular Systems Biology](https://www.embopress.org/cms/asset/f5b0411a-8d92-49d2-a757-2fe0296f46df/msb209628-fig-0001-m.jpg)
In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression | Molecular Systems Biology
![COVID‐19 and renin‐angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) ‐ Is there any scientific evidence for controversy? - Aleksova - 2020 - Journal of Internal Medicine - Wiley Online Library COVID‐19 and renin‐angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) ‐ Is there any scientific evidence for controversy? - Aleksova - 2020 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/8a416ebc-d02d-4b4e-aade-f5267a5111e7/joim13101-toc-0001-m.jpg)
COVID‐19 and renin‐angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) ‐ Is there any scientific evidence for controversy? - Aleksova - 2020 - Journal of Internal Medicine - Wiley Online Library
![Frontiers | DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications? Frontiers | DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?](https://www.frontiersin.org/files/Articles/569989/fphar-11-01161-HTML/image_m/fphar-11-01161-g001.jpg)
Frontiers | DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
![A hypothesis for pathobiology and treatment of COVID‐19: The centrality of ACE1/ACE2 imbalance - Sriram - 2020 - British Journal of Pharmacology - Wiley Online Library A hypothesis for pathobiology and treatment of COVID‐19: The centrality of ACE1/ACE2 imbalance - Sriram - 2020 - British Journal of Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/5017c9b0-9723-4244-a25d-0c30ed29d5e4/bph15082-toc-0001-m.png)
A hypothesis for pathobiology and treatment of COVID‐19: The centrality of ACE1/ACE2 imbalance - Sriram - 2020 - British Journal of Pharmacology - Wiley Online Library
![Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic | Nature Reviews Nephrology Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic | Nature Reviews Nephrology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41581-020-0279-4/MediaObjects/41581_2020_279_Fig1_HTML.png)
Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic | Nature Reviews Nephrology
![IJMS | Free Full-Text | Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms IJMS | Free Full-Text | Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms](https://pub.mdpi-res.com/ijms/ijms-22-06703/article_deploy/html/images/ijms-22-06703-g001.png?1624524857)
IJMS | Free Full-Text | Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms
![IJMS | Free Full-Text | ACE2 and Innate Immunity in the Regulation of SARS-CoV-2-Induced Acute Lung Injury: A Review IJMS | Free Full-Text | ACE2 and Innate Immunity in the Regulation of SARS-CoV-2-Induced Acute Lung Injury: A Review](https://pub.mdpi-res.com/ijms/ijms-22-11483/article_deploy/html/images/ijms-22-11483-g001.png?1635159233)
IJMS | Free Full-Text | ACE2 and Innate Immunity in the Regulation of SARS-CoV-2-Induced Acute Lung Injury: A Review
![COVID-19 and ACE -inhibitors and angiotensin receptor blockers-: The need to differentiate between early infection and acute lung injury | Revista Colombiana de Cardiología COVID-19 and ACE -inhibitors and angiotensin receptor blockers-: The need to differentiate between early infection and acute lung injury | Revista Colombiana de Cardiología](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//01205633/0000002700000003/v1_202008070649/S0120563320300772/v1_202008070649/en/main.assets/gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNc1SMvz46gXX2zWoVNOOjrSljC3HaQAM0e2ci9vr0D6YcESMRhXHrGoUpQcnOUwut9xH6MzcRSZVEC59m1fAsmSZBwgwK8u1YAgwABUM09+BYp8dn4JXbz0B15JnY3mqSu+abGZ6aC0iaZUcyA6k0v+4Dufl440VCEO8BUXpRtjMXScUBvHz+MGgPWNzSJVa2tl3ZXazRSuuFUap0RjSHcPONwQg9ee4YwUOVwSNFmxcYnuD+lUPtU5LbitAcyVlCk=)
COVID-19 and ACE -inhibitors and angiotensin receptor blockers-: The need to differentiate between early infection and acute lung injury | Revista Colombiana de Cardiología
![Cureus | A Review of the Mechanism of Action of Drugs Used in Congestive Heart Failure in Pediatrics | Article Cureus | A Review of the Mechanism of Action of Drugs Used in Congestive Heart Failure in Pediatrics | Article](https://assets.cureus.com/uploads/figure/file/474685/lightbox_7efd6dd0486811eda0a2697ccdeda003-IMG_20221009_224530_450.png)
Cureus | A Review of the Mechanism of Action of Drugs Used in Congestive Heart Failure in Pediatrics | Article
![Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin): A Potential New Therapy for Hypertension | Hypertension Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin): A Potential New Therapy for Hypertension | Hypertension](https://www.ahajournals.org/cms/asset/e69f8532-3802-4a20-a2a5-2c83438419a2/hypertensionaha.121.17041.fig07.jpg)
Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin): A Potential New Therapy for Hypertension | Hypertension
![Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19 | Hypertension Research Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19 | Hypertension Research](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41440-020-0455-8/MediaObjects/41440_2020_455_Fig1_HTML.png)
Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19 | Hypertension Research
![Frontiers | Combination of Angiotensin (1-7) Agonists and Convalescent Plasma as a New Strategy to Overcome Angiotensin Converting Enzyme 2 (ACE2) Inhibition for the Treatment of COVID-19 Frontiers | Combination of Angiotensin (1-7) Agonists and Convalescent Plasma as a New Strategy to Overcome Angiotensin Converting Enzyme 2 (ACE2) Inhibition for the Treatment of COVID-19](https://www.frontiersin.org/files/Articles/620990/fmed-08-620990-HTML/image_m/fmed-08-620990-g001.jpg)
Frontiers | Combination of Angiotensin (1-7) Agonists and Convalescent Plasma as a New Strategy to Overcome Angiotensin Converting Enzyme 2 (ACE2) Inhibition for the Treatment of COVID-19
![Coronavirus Disease 2019 (COVID‐19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 ... Coronavirus Disease 2019 (COVID‐19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 ...](https://www.ahajournals.org/cms/asset/88f7a9ce-acaf-4167-9aed-5d2f8554d660/jah35034-fig-0001.png)